Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: EVP Research & Development of $CYTK Sells 3,500 Shares

Automated

Fady Ibraham Malik, the EVP Research & Development of $CYTK, sold 3,500 shares of the company on 06-09-2026 for an estimated $237,930. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.2% of their shares of this class of stock. Following this trade, they now own 153,902 shares of this class of $CYTK stock.

$CYTK Insider Trading Activity

CYTK Insider Trades

$CYTK insiders have traded $CYTK stock on the open market 43 times in the past 6 months. Of those trades, 0 have been purchases and 43 have been sales.

Here’s a breakdown of recent trading of $CYTK stock by insiders over the last 6 months:

  • ANDREW CALLOS (EVP, Chief Commercial Officer) has made 0 purchases and 18 sales selling 126,633 shares for an estimated $8,232,891.
  • ROBERT I BLUM (President & CEO) has made 0 purchases and 8 sales selling 82,032 shares for an estimated $5,357,022.
  • FADY IBRAHAM MALIK (EVP Research & Development) has made 0 purchases and 10 sales selling 35,640 shares for an estimated $2,355,631.
  • SUNG LEE (EVP, Chief Financial Officer) has made 0 purchases and 2 sales selling 28,841 shares for an estimated $2,144,364.
  • WENDELL WIERENGA has made 0 purchases and 2 sales selling 24,032 shares for an estimated $1,625,200.
  • JOHN T HENDERSON sold 20,000 shares for an estimated $1,519,400
  • B LYNNE PARSHALL sold 5,000 shares for an estimated $370,400
  • EDWARD M. MD KAYE sold 2,933 shares for an estimated $223,171

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CYTK Hedge Fund Activity

We have seen 250 institutional investors add shares of $CYTK stock to their portfolio, and 225 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CYTK Analyst Ratings

Wall Street analysts have issued reports on $CYTK in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Barclays issued a "Overweight" rating on 01/28/2026
  • Needham issued a "Buy" rating on 12/22/2025
  • HC Wainwright & Co. issued a "Buy" rating on 12/22/2025
  • Citizens issued a "Market Outperform" rating on 12/22/2025
  • Goldman Sachs issued a "Buy" rating on 12/19/2025

To track analyst ratings and price targets for $CYTK, check out Quiver Quantitative's $CYTK forecast page.

$CYTK Price Targets

Multiple analysts have issued price targets for $CYTK recently. We have seen 16 analysts offer price targets for $CYTK in the last 6 months, with a median target of $99.5.

Here are some recent targets:

  • Eric Joseph from Citigroup set a target price of $99.0 on 05/19/2026
  • Tessa Romero from JP Morgan set a target price of $97.0 on 05/12/2026
  • Joseph Pantginis from HC Wainwright & Co. set a target price of $140.0 on 05/11/2026
  • Yanan Zhu from Wells Fargo set a target price of $105.0 on 05/07/2026
  • Leonid Timashev from RBC Capital set a target price of $119.0 on 05/06/2026
  • Jeffrey Hung from Morgan Stanley set a target price of $103.0 on 05/06/2026
  • James Condulis from Stifel set a target price of $108.0 on 05/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles